Skip to content
Chemtech Medical Changes To Medtech
Chemtech Medical Changes To Medtech
ZEISS QUATERA 700: Comparative Analysis of Chamber Stability

ZEISS QUATERA 700: Comparative Analysis of Chamber Stability

The QUATERA® 700 from ZEISS represents a significant advancement in cataract surgery, utilizing the patented ZEISS QUATTRO Pump® to achieve stable chamber conditions independent of intraocular pressure (IOP) or aspiration flow.

Fanney D, et al. Journal of Cataract & Refractive Surgery 2023

 

  • Unmatched Stability
  • Game-changing performance
  • Unprecedent efficiency
  • Next-generation innovation

 

Learn more - https://medtech.mu/blogs/news/zeiss-quatera-700-revolutionizes-cataract-surgery

A study conducted using a laboratory-based spring eye model compared intraocular pressure (IOP) against variations in aspiration flow rate (AFR) and incision leakage for two different phaco systems.


Results & Observations

Stability at varying Flow rates

ZEISS QUATERA 700 maintained target IOP up to 90 cc/min, whereas the Competitor A system began to lose stability beyond 50 cc/min.

Surge Duration shorter and consistent

The QUATTRO Pump® in ZEISS QUATERA 700 rapidly restores fluid following occlusion break, resulting in shorter and more consistent surge durations. The system’s performance was also less impacted by vacuum level compared to Competitor A.

Active incisional leakage up to 15 cc/min

ZEISS QUATERA 700's advanced control system effectively compensates for variations in leakage flow during aspiration, providing superior chamber stability, outperforming Competitor A's Active Fluidics.

 

Learn more about Quatera 700

https://www.zeiss.com/meditec/en/c/quatera-700/zeiss-quatera-700-ensures-chamber-stability.html

 


For more product information

Contact: Urvashi Sumoondur

Ophthalmology Product Specialist

UrvashiS@medtech.mu

+230 5 938 9225

Book a Consultation

 

Next article From Prevention to Innovation: Transforming Kidney Health in 2025